-+ 0.00%
-+ 0.00%
-+ 0.00%

Ocular Therapeutix to Present Phase 3 SOL-1 Wet AMD Trial Results at Macula Society Meeting

Reuters·02/05/2026 12:05:59

Please log in to view news